Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC

European Journal of Cardio-thoracic Surgery

Volumn 25, Issue 3, 2004, Pages 443-448

  Iwasaki, Akinori ^a   Kuwahara, Motohisa ^a   Yoshinaga, Yasuteru ^a   Shirakusa, Takayuki ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Angiogenetic factor; Basic fibroblast growth factor; Histological type; Lung cancer; Vascular endothelial growth factor

Indexed keywords

FIBROBLAST GROWTH FACTOR; SCATTER FACTOR; TISSUE EXTRACT; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; LYMPH NODE; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TISSUE SECTION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1542719213     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2003.11.031     Document Type: Article

References (25)

1. Li M., Ye C., Feng C., Riedel F., Liu X., Zeng Q., Grandis J.R. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy. Clin Cancer Res. 8:(11):2002;3570-3578.
2. Halin C., Niesner U., Villani M.E., Zardi L., Neri D. Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins. Int J Cancer. 102:(2):2002;109-116.
3. Liu M., Xin Y.-L., Chen F.-M. Immunohistochemical study of transforming growth factor-alpha in human lung cancers. Tumor Biol. 13:1992;294-298.
4. Derynck R.D., Goeddle V., Ullrich A., Gutterman J.U., Williams R.D., Bringman T.S., Berger W.H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res. 47:1987;707-712.
5. Klagsbrun M. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor(bFGF)-heparin and heparan sulfate interaction. Semin Cancer Biol. 3:1992;81-87.
6. Lund E.L., Thorsen C., Pedersen M.W., Junker N., Kristjansen P.E. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro. Clin Cancer Res. 6:(11):2000;4287-4291.
7. Mattern J., Kooaagi Rand Volm M. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res. 17:1997;2249-2252.
8. Volm M., Koomagi R., Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer. 74:1997;64-68.
9. Tamura M., Ohta Y., Kajita T., Kimura K., Go T., Oda M., Nakamura H., Watanabe G. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer. Oncol Rep. 8:(5):2001;1097-1102.
10. Siegfried J.M., Weissfeld L.A., Singh-Kaw P., Weyant R.J., Testa J.R., Landreneau R.J. Association of immunoreactive hepatocyte growth factor with poor survival in respectable non-small cell lung cancer. Cancer Res. 57:1997;433-439.
11. Tsao M.S., Yang Y., Marcus A., Liu N., Mou L. Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer. Hum Pathol. 32:(1):2001;57-65.
12. Tandon A.K., Clark G.M., Chamness G.C., Chrigwin J.M., McGuire W.L. Cathepsin D and prognosis in breast cancer. N Engl J Med. 322:1990;297-302.
13. Kojima H., Shijubo N., Abe S. Thymidine phosphorylase and vascular endothelial growth factor in patients with stage I lung adenocarcinoma. Cancer. 94:2002;1083-1093.
14. Joensuu H., Anttonen A., Eriksson M., Makitaro R., Alfthan H., Kinnula V., Leppa S. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res. 62:(18):2002;5210-5217.
15. Ohno M., Nakamura T., Kunimoto Y., Nishimura K., Chung-Kang C., Kuroda Y. Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer. Oncol Rep. 10:(4):2003;939-943.
16. Blattstrom D., Bergqvist M., Larsson A., Holmertz J., Hesserlius P., Rosenberg L., Brodin O., Wagenius G. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non small cell lung cancer patients. Anticancer Res. 18:1998;1123-1127.
17. Guddo F., Fontanini G., Reina C., Vignola A.M., Angeletti A., Bonsignore G. The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression. Hum Pathol. 30:1999;788-794.
18. Mattern J., Koomaagi R., Volm M. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma in associated with increased vessel density. Anticancer Res. 17:1997;2249-2252.
19. Fontanini G., Bigini D., Vignati S., Basolo F., Mussi A., Lucchi M., Chine S., Angeletti C.A., Harris A.L., Bevilacqua G. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol. 177:1995;57-63.
20. Macchiarini P., Fontanini G., Hardin J.M., Sqartini F., Angeletti C.A. Relation of neovascularisation to metastasis of non-small cell lung cancer. Lancet. 340:1992;45-46.
21. Fontanini G., Vignati S., Bigini D., Mussi A., Lucchi M., Chine S., Angeletti C.A., Bevilacqcua G. Recurrence and death in non-small cell lung carcinoma: a prognostic model using pathological parameters, microvessel count, and gene protein products. Clin Cancer Res. 2:1996;1067-1075.
22. White E.S., Flshrty K.R., Carskadon S., Brant A., Iannettoni M.D., Yee J., Orringer M.B., Arenberg D.A. Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res. 9:1997;853-860. See also pages 433-439.
23. Fuhrmann-Benzakein E., Ma M.N., Rubbia-Brandt L., Mentha G., Ruefenacht D., Sappino A.P., Pepper M.N.S. Elevated levels of angiogenetic cytokines in the plasma of cancer patients. Int J Cancer. 85:2000;40-45.
24. Takayama K., Ueno H., Nakanishi Y., Sakamoto T., Inoue K., Shimizu K., Oohashi H., Hara N. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Cancer Res. 60:(8):2000;2169-2177.
25. Menzel T., Rahman Z., Calleja E., White K., Wilson E.L., Wieder R., Gabrilove J. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood. 87:1996;1056-1063.